Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease-Reference-Cited by-同舟云学术

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease

Published:2014-07 Issue:4 Volume:10 Page:421
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Hill Derek L.G.¹,Schwarz Adam J.²,Isaac Maria³,Pani Luca³,Vamvakas Spiros³,Hemmings Robert³,Carrillo Maria C.⁴,Yu Peng²,Sun Jia²⁵,Beckett Laurel⁶,Boccardi Marina⁷,Brewer James⁸,Brumfield Martha⁹,Cantillon Marc¹⁰,Cole Patricia E.²,Fox Nick¹¹,Frisoni Giovanni B.⁷,Jack Clifford¹²,Kelleher Thomas¹³,Luo Feng¹³,Novak Gerald¹⁴,Maguire Paul¹⁵,Meibach Richard¹⁶,Patterson Patricia¹⁷,Bain Lisa¹⁸,Sampaio Cristina¹⁹,Raunig David²⁰,Soares Holly¹³,Suhy Joyce²¹,Wang Huanli⁶,Wolz Robin¹²²,Stephenson Diane⁹

Affiliation:

1. IXICO Ltd.LondonUK

2. Eli Lilly and CompanyIndinapolisINUSA

3. European Medicines AgencyLondonUK

4. Alzheimer's AssociationChicagoILUSA

5. The University of Texas School of Public HealthHoustonTXUSA

6. University of CaliforniaDavisCAUSA

7. IRCCS FatebenefratelliBresciaItaly

8. University of CaliforniaSan DiegoCAUSA

9. Coalition Against Major DiseasesCritical Path InstituteTucsonAZUSA

10. Wellnessmanagments.comLivingstonNJUSA

11. UCL Institute of NeurologyLondonUK

12. Mayo ClinicRochesterMNUSA

13. Bristol Myers SquibbWallingfordCTUSA

14. Janssen Pharmaceutical Research and DevelopmentTitusvilleNJUSA

15. NovartisBaselSwitzerland

16. NovartisNJUSA

17. AstraZenecaWilmingtonDEUSA

18. Independent science writerElversonPAUSA

19. CHDI Foundation Inc.PrincetonNJUSA

20. ICON Medical ImagingWarringtonPAUSA

21. SYNARC Inc.NewarkCAUSA

22. Department of ComputingImperial College LondonLondonUK

Funder

Science Foundation Arizona

US Food and Drug Association

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2013.07.003

Reference73 articles.

1. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

2. Alliance for Aging Research AD Biomarkers Work Group: structural MRI

3. A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort

4. European Medicines Agency.Qualification of novel methodologies for drug development: guidance to applicants.Accessed November 21 2012. Available from:http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004201.pdf. 2012.

5. Food and Drug Administration.Innovation or stagnation: challenges and opportunity on the critical path to new medical products.Accessed February 26 2013. Available from:http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm. 2004.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A brain subcortical segmentation tool based on anatomy attentional fusion network for developing macaques;Computerized Medical Imaging and Graphics;2024-09

2. MRI‐based axis‐referenced morphometric model corresponding to lamellar organization for assessing hippocampal atrophy in dementia;Human Brain Mapping;2024-07-12

3. Vulnerability of the Hippocampus to Insults: Links to Blood–Brain Barrier Dysfunction;International Journal of Molecular Sciences;2024-02-06

4. CirMNet: A Shape-Based Hybrid Feature Extraction Technique Using CNN and CMSMD for Alzheimer’s MRI Classification;IEEE Access;2024

5. Geodesic shape regression based deep learning segmentation for assessing longitudinal hippocampal atrophy in dementia progression;NeuroImage: Clinical;2024